Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Submitted by
admin
on August 22, 2011 - 6:13pm
Source:
Bloomberg
News Tags:
Seattle Genetics
Dendreon
Provenge
Adcetris
lymphoma
Headline:
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Do Not Allow Advertisers to Use My Personal information
